Trax to Prepare Pharma Companies for California Climate
Trax’s existing use of European Sustainability Reporting Standards give pharmaceutical companies a competitive advantage in reducing scope 3 emissions...
Stay updated with breaking news from Steve Beda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trax’s existing use of European Sustainability Reporting Standards give pharmaceutical companies a competitive advantage in reducing scope 3 emissions...
Trax’s existing use of European Sustainability Reporting Standards give pharmaceutical companies a competitive advantage in reducing scope 3 emissionsDALLAS, Jan. 09, 2024 (GLOBE NEWSWIRE) -- A recent McKinsey report revealed an “analysis of approximately 40 pharmaceutical companies shows that about 75 percent of emissions across the value chain are Scope 3, with 50 percent of the total emissions coming from upstream, specifically the purchased goods and services category.” Trax Technologies (Tr
Trax eBook Reveals supply chain sustainability challenges, strategies, and outlook
-Trax eBook Reveals supply chain sustainability challenges, strategies, and outlook-
Trax and TriumphPay executives co-present strategies for mitigating transportation fraud risks, while gaining end-to-end visibility into carbon emissions for reporting and reduction purposes -